Literature DB >> 26039881

Erratum: Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.

Huayong Liu1, Yanfeng Zhao2, Dan Zhao3, Ting Gong1, Youcong Wu1, Haiyan Han1, Tao Xu1, Andreas Peschel4, Shiqing Han3, Di Qu1.   

Abstract

[This corrects the article DOI: 10.1038/emi.2015.1.].

Entities:  

Year:  2015        PMID: 26039881      PMCID: PMC4355440          DOI: 10.1038/emi.2015.17

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


Corrigendum to: Emerging Microbes and Infections (2015) 4, e1; doi:10.1038/emi.2015.1; published online 7 January 2015 The authors apologized for an error in the second affiliation. The original affiliation “Department of Laboratory Medicine, Affiliated Gulou Hospital, Medical College of Nanjing University, Nanjing 210008, Jiangsu, China” should be changed to: “Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China”.
  3 in total

1.  Antimicrobial and anti-biofilm activity of hexadentated macrocyclic complex of copper (II) derived from thiosemicarbazide against Staphylococcus aureus.

Authors:  Umarani Brahma; Richa Kothari; Paresh Sharma; Vasundhra Bhandari
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

2.  SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells.

Authors:  Pengfei She; Yaqian Liu; Lanlan Xu; Yimin Li; Zehao Li; Shasha Liu; Zubair Hussain; Yong Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-03-18       Impact factor: 5.293

Review 3.  Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-β with Regard to Potential Treatment and Prevention.

Authors:  Herbert B Allen
Journal:  J Alzheimers Dis       Date:  2016-06-27       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.